| ￥1200 | |
| A03090-50 | |
|
|
|
|
|
|
|
|
|
| Specificity | This product is specific to HLA DRA |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human HLA DRA |
| Species Reactivity | Human |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||||
|
|||||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
| Target Background | An alpha chain of antigen-presenting major histocompatibility complex class II (MHCII) molecule. In complex with the beta chain HLA-DRB, displays antigenic peptides on professional antigen presenting cells (APCs) for recognition by alpha-beta T cell receptor (TCR) on HLA-DR-restricted CD4-positive T cells. |
| Synonyms | HLA-DR; MLRW; HLA-DRA1; MHC class II antigen DRA; HLA class II histocompatibility antigen, DR alpha chain; HLA DRB1; DRA; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
